Secondary prevention of Acute Coronary Syndrome: Where are we now? Â a Cardiology Expert Symposium
14 Oct 2021
About the event
This will be Sanofi led educational meeting that will be held via zoom. The speakers are all doctors/professors who are experts in the field of Cardiology. The objectives are:; To communicate how HCPs can impact a patients CV residual risk in the post-MI follow-up or secondary prevention clinic ; To highlight the impact cardiologists can make in the area of secondary prevention for patients in secondary care; Discussion will be encouraged after each presentation and the meeting will finish with a debate that will include all three speakers and the chair.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare.